The US Food and Drug Administration (FDA) has approved an expanded indication for MED-EL’s SYNCHRONY cochlea implants in infants aged seven months and older with bilateral sensorineural hearing loss ...
The cochlear implant systems that we know today with small designs and built-in future-ready technology have come a long way since Austrian scientists Ingeborg and Erwin Hochmair began working on ...
MED-EL’s cochlear implant system is the only FDA-approved option for infants this young, and the FDA action also included expansion of other audiologic and speech indications for children aged 12 ...
A study from Ann & Robert H. Lurie Children's Hospital of Chicago found that children with a MED-EL Synchrony cochlear implant device can undergo MRI safely, with no discomfort and reduced need for ...
DURHAM, N.C., April 29, 2026--(BUSINESS WIRE)--Hearing implant leader MED-EL USA is announcing two upcoming symposia at CI2026, the annual meeting of the American Cochlear Implant Association (ACIA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results